updated 1/29/2013 6:46:50 AM ET 2013-01-29T11:46:50

(Reuters) - Eli Lilly and Co said on Tuesday that fourth-quarter earnings had fallen as competition from generic drugs drove revenue lower.

The U.S. drugmaker said it had earned $827 million, or 74 cents per share, compared with $858 million, or 77 cents per share, a year earlier.

Excluding special items such as asset impairments, restructuring and other special charges, Lilly earned 85 cents per share. Analysts on average were expecting 78 cents per share.

(Reporting By Caroline Humer and Ransdell Pierson; Editing by Lisa Von Ahn)

(c) Copyright Thomson Reuters 2013. Check for restrictions at: http://about.reuters.com/fulllegal.asp

Discuss:

Discussion comments

,

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.98%
$30K home equity loan FICO 6.17%
$75K home equity loan FICO 5.94%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 11.01%
11.01%
Cash Back Cards 16.34%
16.34%
Rewards Cards 15.80%
15.80%
Source: Bankrate.com
  1. Jump to text

    (Reuters) - Eli Lilly and Co said on Tue...

  2. Jump to discussion

    Lilly fourth-quarter profit fall as generics hur...

  3. Jump to data

    See the latest rates around the country